Identification of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) as therapeutic targets for pancreatic cancer.

被引：0
|
作者：
Della Croce, K
Han, H
Beroza, P
Bearss, DJ
von Hoff, DD
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Telik Inc, S San Francisco, CA USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72
引用
收藏
页码：3668S / 3668S
页数：1
相关论文
共 50 条
  • [1] Targeting the Urokinase Plasminogen Activator Receptor (uPAR)/Urokinase Plasminogen Activator (uPA) System in Acute Myeloid Leukemia
    Mroz, Pawel
    Kosciuczuk, Ewa
    Mazer, Andrew
    Platanias, Leonidas
    LABORATORY INVESTIGATION, 2015, 95 : 366A - 366A
  • [2] Targeting the Urokinase Plasminogen Activator Receptor (uPAR)/Urokinase Plasminogen Activator (uPA) System in Acute Myeloid Leukemia
    Mroz, Pawel
    Kosciuczuk, Ewa
    Mazan, Andrew
    Platanias, Leonidas
    MODERN PATHOLOGY, 2015, 28 : 366A - 366A
  • [3] Urokinase plasminogen activator receptor (uPAR) as a novel biomarker in prostate cancer.
    Lippert, Solvej
    Berg, Kasper Drimer
    Iversen, Peter
    Hoyer-Hansen, Gunilla
    Christensen, Ib Jarle
    Brasso, Klaus
    Roder, M. Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells.
    Hjertner, O
    Westin, J
    BLOOD, 1999, 94 (10) : 549A - 549A
  • [5] Expression of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) in prostatic adenocarcinoma (PAC) correlates with tumor grade and stage.
    Anwar, S
    Jennings, TA
    Depowski, PL
    Ross, JS
    Nazeer, T
    LABORATORY INVESTIGATION, 2001, 81 (01) : 101A - 101A
  • [6] Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
    Bing-Tao Zhai
    Huan Tian
    Jing Sun
    Jun-Bo Zou
    Xiao-Fei Zhang
    Jiang-Xue Cheng
    Ya-Jun Shi
    Yu Fan
    Dong-Yan Guo
    Journal of Translational Medicine, 20
  • [7] Expression of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) in prostatic adenocarcinoma (PAC) correlates with tumor grade and stage.
    Anwar, S
    Jennings, TA
    Depowski, PL
    Ross, JS
    Nazeer, T
    MODERN PATHOLOGY, 2001, 14 (01) : 101A - 101A
  • [8] Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer
    Montuori, Nunzia
    Pesapane, Ada
    Rossi, Francesca W.
    Giudice, Valentina
    De Paulis, Amato
    Selleri, Carmine
    Ragno, Pia
    TRANSLATIONAL MEDICINE AT UNISA, 2016, 15 : 15 - 21
  • [9] Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
    Zhai, Bing-Tao
    Tian, Huan
    Sun, Jing
    Zou, Jun-Bo
    Zhang, Xiao-Fei
    Cheng, Jiang-Xue
    Shi, Ya-Jun
    Fan, Yu
    Guo, Dong-Yan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [10] UROKINASE PLASMINOGEN ACTIVATOR (UPA) AND ATHEROSCLEROSIS
    Fuhrman, B.
    Khateeb, J.
    Lati, Y.
    Aviram, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 63 - 64
12345